Titel | The use of Iridium Brachytherapy in multifocal and non-limbal conjunctival melanoma |
Abstract Nr. | 1026 |
Doel | To describe technique, possibilities and outcome for Iridium brachytherapy in conjunctival melanoma. As data show that irradiation decreases the number of recurrences and has a trend to give better survival in conjunctival melanomas, iridium brachytherapy was used as adjuvant therapy in difficult cases. |
Methodes | Description of seven patients with conjunctival melanoma. |
Resultaten | In seven patients with non-limbal conjunctival melanoma, iridium needles were used to apply irradiation of the tumor beds. A mean follow-up of 3 years was found. No recurrences were detected. One patient died due to his melanoma within 2 years after treatment of the primary tumor. In one patient a scleral thinning was found. All patients have transient dry eye syndrome, and (temporal) loss of eye lashes. None of the patients show irradiation retinopathy or cataract within the follow-up period. In one patient the treatment could be safely combined with strontium plaque therapy for a large perilimbal component. |
Conclusie | Iridium brachytherapy is a safe adjuvant procedure for the treatment of extended and multifocal non-limbal conjunctival melanomas, which gives good local control. |
Naam | MISSOTTEN |
Initialen | G |
Instituut | Katholieke Universiteit Leuven |
Stad | Leuven |
Naam | Van Limbergen |
Initialen | E |
Instituut | Katholieke Universiteit Leuven |
Stad | Leuven |
Naam | Spileers |
Initialen | W |
Instituut | Katholieke Universiteit Leuven |
Stad | Leuven |